Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
Authors
Keywords
-
Journal
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 326, Issue 6, Pages 499
Publisher
American Medical Association (AMA)
Online
2021-07-07
DOI
10.1001/jama.2021.11330
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
- (2021) Viviane C Veiga et al. BMJ-British Medical Journal
- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
- (2021) Ivan O. Rosas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) François-Xavier Lescure et al. Lancet Respiratory Medicine
- Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
- (2021) Arvinder S Soin et al. Lancet Respiratory Medicine
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials
- (2021) Jayne F. Tierney et al. PLOS MEDICINE
- Interleukin-6: obstacles to targeting a complex cytokine in critical illness
- (2021) Oliver J McElvaney et al. Lancet Respiratory Medicine
- A minimal common outcome measure set for COVID-19 clinical research
- (2020) John C Marshall et al. LANCET INFECTIOUS DISEASES
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- (2020) Divij Mathew et al. SCIENCE
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
- (2020) Daniel E Leisman et al. Lancet Respiratory Medicine
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Random-Effects Meta-analysis
- (2018) Stylianos Serghiou et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?
- (2017) David J Fisher et al. BMJ-British Medical Journal
- Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?
- (2017) David J Fisher et al. BMJ-British Medical Journal
- Unknown
- (2017) Research Synthesis Methods
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now